当前位置:主页 > 医学论文 > 神经病学论文 >

以机械取栓为主的动脉内多模式方法治疗急性大动脉闭塞性脑梗死的效果分析

发布时间:2018-10-05 09:26
【摘要】:目的 探讨对急性大动脉闭塞性脑梗死患者接受以机械取栓为主的动脉内多模式方法治疗的有效性和安全性及其影响预后的相关因素。方法 回顾性分析56例急性大动脉闭塞性脑梗死患者的临床资料,观察临床特点(性别、年龄、相关基础疾病)、治疗时机(发病至穿刺时间、穿刺至开通时间)、多模式治疗(动脉内溶栓、取栓、球囊扩张、支架置入等)、责任血管分布等项目。评估血管再通情况采用改良脑梗死溶栓试验(m TICI)分级,观察术前和术后24 h神经功能采用美国国立卫生研究院卒中量表(NIHSS)评分,采用改良Rankin量表(mRS)评价术后3个月预后。根据术后3个月预后情况将入组患者分为预后良好组(34例,mRS≤2分)和预后不良组(22例,mRS≥3分),行单因素分析,再进一步行多因素Logistic回归分析影响预后的因素。结果 (1)56例患者血管再通率为78.6%(44例),其中基底动脉最高,达93.8%(15/16),大脑中动脉87.0%(20/23)。治疗后24 h NIHSS评分(10±7)分,低于入院时的(16±6)分,差异有统计学意义(t=6.401,P0.01)。3个月预后良好34例(60.7%),死亡4例(7.1%),症状性颅内出血8例(14.3%)。(2)多因素分析显示:血管再通级别高,是良好预后的保护因素(OR=0.465,95%CI:0.267~0.809,P=0.007);糖尿病是预后不良的独立危险因素(OR=5.535,95%CI:1.101~27.835,P=0.038)。结论 急性大动脉闭塞性脑梗死动脉内多模式治疗能快速有效地恢复颅内血流,具有开通率高和预后好的特点。并且血管再通级别越高,预后越好。而糖尿病是预后不良的独立危险因素。
[Abstract]:Objective to investigate the efficacy, safety and prognostic factors of mechanical embolization in patients with acute arterial occlusive cerebral infarction. Methods the clinical data of 56 patients with acute arterial-occlusive cerebral infarction were retrospectively analyzed. The clinical features (sex, age, related basic diseases) and the time of treatment (from onset to puncture) were observed. Puncture to the opening time), multi-mode therapy (intraarterial thrombolysis, balloon dilation, stent implantation, etc.), responsible vascular distribution and so on. The recanalization of blood vessels was evaluated by modified thrombolytic test (m TICI). The neurological function was evaluated by the (NIHSS) scale of the National Institutes of Health before and 24 hours after operation, and the prognosis was evaluated by the modified Rankin scale (mRS) at 3 months after operation. According to the prognosis of 3 months after operation, the patients were divided into good prognosis group (34 cases with MRs 鈮,

本文编号:2252859

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2252859.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户bea02***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com